Completed SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4 NCT02941328 Conditions Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +12 more Locations University Medical Center of Utrecht (UMCU) — Utrecht, Netherlands View Trial Details
